Immunophenotype, mRNA expression, and gene structure of p53 in Wilms' tumors

Modern Pathology

Volumn 9, Issue 3, 1996, Pages 238-244

  El Bahtimi, Reem ^a   Hazen Martin, Debra J ^a   Re, Gian G ^a   Willingham, Mark C ^a   Garvin, A Julian ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Anaplasia; P53 mutation; Wilms' tumor

Indexed keywords

MESSENGER RNA; PROTEIN P53;

ADOLESCENT; ADULT; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; NEPHROBLASTOMA; NORTHERN BLOTTING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENOTYPE; HUMANS; IMMUNOPHENOTYPING; INFANT; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; WILMS TUMOR;

EID: 0030011653     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Re GG, Hazen-Martin DJ, Sens DA, Garvin AJ: Nephroblastoma (Wilms' tumor): A model system of aberrant renal development. Semin Diagn Pathol 11:126, 1994.
2. Beckwith JB: Precursor lesions of Wilms' tumor: Clinical and biological implications. Med Pediatr Oncol 21:158, 1993.
3. Green DM, Beckwith JB, Breslow NE, et al.: Treatment of children with stages II to IV anaplastic Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 12:2126, 1994.
4. Takeuchi S, Bartram CR, Lukwig R, et al.: Mutations of p53 in Wilms' tumors. Mod Pathol 8:483, 1995.
5. Bardeesy N, Falkoff DF, Petruzzi M-J, et al.: Anaplastic Wilms' tumor, a subtype displaying poor prognosis, harbors p53 gene mutations. Nature Genet 7:91, 1994.
6. Bardeesy N, Beckwith BJ, Pelletier J: Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations. Cancer Res 55:215, 1995.
7. Malkin D, Sexsmith E, Yeger H, Williams BRG, Coppes M: Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor. Cancer Res 54:2077, 1994.
8. Nguyen KT, Liu B, Ueda K, et al.: Transactivation of the human multidrug resistance (MDR1) gene promoter by p53 mutants. Oncol Res 6:71, 1994.
9. Lane DP, Crawford LV: T antigen is bound to a host protein in SV 40-transformed cells. Nature 278:261, 1979.
10. Sarnow P, Ho YS, Williams J, Levine AJ: Adenovirus Elb-58 Kd tumor antigen and SV 40 large tumor antigen are physically associated with the same 54 Kd cellular protein in transformed cells. Cell 28:387, 1982.
11. Esrig D, Spruck CH III, Nichols PW, et al.: p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 143:1389, 1993.
12. Lemoine NR, Hughies CM, Cowell JK: Aberrant expression of the tumor suppressor gene p53 is very frequent in Wilms' tumors. J Pathol 168:237, 1992.
13. Van den Berg FM, Baas IO, Polak MM, Offerhaus JA: Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid. Am J Pathol 142:381, 1993.
14. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162:156, 1987.
15. Re GG, Antoun GR, Zipf TF: Modulation of a constitutive transcriptional block at exon-1 controls human c-myc oncogene expression. Oncogene 5:1247, 1990.
16. Lamb P, Crawford L: Characterization of the human p53 gene. Mol Cell Biol 1379, 1986.
17. Orita M, Suzuki Y, Sekiya T, Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphism using the polymerase chain reaction. Genomics 5:874, 1989.
18. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253:49, 1991.
19. Symonds H, Krall L, Remington L, et al.: p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78:703, 1994.
20. Prives C: How loops, β-sheets, and α-helices help us to understand p53. Cell 78:543, 1994.